您当前的位置：
首页 >
文章列表页 >
Research progress on antibody-drug conjugates in the treatment of triple-negative breast cancer
更新时间：2026-02-10

    • Research progress on antibody-drug conjugates in the treatment of triple-negative breast cancer

    • “Antibody coupled drugs (ADCs) have made new progress in the field of triple negative breast cancer (TNBC) treatment. A variety of targeted ADCs show good efficacy and are changing the pattern of TNBC treatment.”
    • ZHONGGUO YAOFANG   Vol. 37, Issue 1, Pages: 124-129(2026)

    • DOI：10.6039/j.issn.1001-0408.2026.01.22    

      CLC： R979.1

    • Received：08 August 2025，

      Revised：2025-12-16，

      Accepted：17 December 2025，

      Published：15 January 2026

    移动端阅览

  • LIU Danna,SONG Shuangshuang,CHEN Lu,et al.Research progress on antibody-drug conjugates in the treatment of triple-negative breast cancer[J].ZHONGGUO YAOFANG,2026,37(01):124-129. DOI： 10.6039/j.issn.1001-0408.2026.01.22.

  •  
  •  

0

Views

7

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

No data

Related Author

No data

Related Institution

No data
0